A 12-Week Randomized Trial Finds NeuroAnimation May Support Both Motor Coordination and Cognitive Wellness in Parkinson’s Disease
Published in the Journal of NeuroEngineering and Rehabilitation, this is the first randomized controlled trial combining NeuroAnimation with physiotherapy in an intensive Parkinson’s program.
Study Context
A randomized controlled trial published in the Journal of NeuroEngineering and Rehabilitation evaluated NeuroAnimation alongside physiotherapy in a 12-week intensive Parkinson’s wellness program. The immersive experience required participants to make 3D arm movements to in a NeuroAnimation’s immersive experience, simultaneously engaging physical coordination and cognitive processing.
The Evidence
The trial measured outcomes across motor coordination, cognitive-motor function using the Timed Up and Go cognitive test, and participant engagement. The NeuroAnimation group showed meaningful improvements in cognitive-motor function compared to physiotherapy alone. Benefits were cumulative; gains continued to build even after the program concluded. No serious adverse events were reported.
Key Finding
12 weeks
Cumulative and sustained benefits were observed, with gains continuing to develop after the program ended. (Journal of NeuroEngineering and Rehabilitation)
What The Research Shows
- Significant improvements in cognitive-motor function compared to the physiotherapy-only group
- Over 80% of participants reported satisfaction with the NeuroAnimation program
- 67% full program completion rate, notably high for a 12-week intensive protocol
- Safe and well-tolerated, with no serious adverse events across the trial period
What This May Mean For You
NeuroAnimation supported people living with Parkinson’s and their families. This trial offers evidence that a single program can engage both physical movement and cognitive function simultaneously, and that the benefits may continue developing even after structured sessions end.
